1 – 10 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Economic Burden of Parkinson’s Disease : A Multinational, Real-World, Cost-of-Illness Study
2024) In Drugs - Real World Outcomes(
- Contribution to journal › Article
-
Mark
The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson’s Disease
2024) In Journal of Geriatric Psychiatry and Neurology(
- Contribution to journal › Article
-
Mark
Care of Late-Stage Parkinsonism : Resource Utilization of the Disease in Five European Countries
(
- Contribution to journal › Article
-
Mark
A systematic practice review : Providing palliative care for people with Parkinson’s disease and their caregivers
(
- Contribution to journal › Scientific review
-
Mark
Non-Motor Symptom Management : Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients
(
- Contribution to journal › Article
-
Mark
Meaning in Life in Late-Stage Parkinson’s Disease : Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European Countries
(
- Contribution to journal › Article
- 2023
-
Mark
The Relationship between PDQ-8 and Costs in Parkinson's Disease—A Swedish Register-Based Study
(
- Contribution to journal › Article
-
Mark
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease
2023) In European Journal of Neurology(
- Contribution to journal › Article
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
(
- Contribution to journal › Article
-
Mark
Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment
(
- Contribution to journal › Scientific review